Graf Akcie BLUE (Bluebird bio Inc). Diskuze k akciím BLUE. Aktuální informace BLUE.

Základní informace o společnosti Bluebird bio Inc (Akcie BLUE)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.39B
Hodnota podniku (EV) 376.04M
Tržby 50.247M
EBITDA -835.66
Zisk -842.13
Růst v tržbách Q/Q -96.24 %
Růst v tržbách Y/Y -79.03 %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 7.48
EV/EBITDA N/A
EV/EBIT N/A
PEG 0.04
Price/Sales 27.68
P/FCF N/A
Price/Book 1.03
Účetní hodnota na akcii 20.08
Hotovost na akcii 17.06
FCF vůči ceně -48.58 %
Počet zaměstnanců 1,213
Tržba na zaměstnance 41.424k
Profit margin -246.75 %
Operating margin -1,725.50 %
Gross margin 97.85 %
EBIT margin -1,683.00 %
EBITDA margin -1,663.11 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 894.44 %
EPS - Očekávaný růst příští rok -9.86 %
Return on assets -49.40 %
Return on equity -66.53 %
ROIC -35.89 %
ROCE -70.08 %
Dluhy/Equity 0.31
Čistý dluh/EBITDA 4.12
Current ratio 3.65
Quick Ratio 3.59
Volatilita 3.93
Beta 0.48
RSI 62.98
Cílová cena analytiků 82
Známka akcie (dle analytiků) 1.67
Insider ownership 1.49 %
Institutional ownership 80.80 %
Počet akcií 67.579M
Procento shortovaných akcií 9.79 %
Short ratio 4.97 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie BLUE

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$250.734$44.674$54.579$35.427$6.155$14.079
Cost Of Goods Sold$5.396$2.978$0.885$1.527--
Gross Profit$245.338$41.696$53.694$33.9$6.155$14.079
Research And Development Expenses$587.956$582.413$448.589$273.04$204.775$134.038
SG&A Expenses$286.896$271.362$174.129$93.55$65.119$46.209
Other Operating Income Or Expenses$6.468$-2.747$-2.999$0.525$-4.091$-2.869
Operating Expenses$873.78$859.5$626.602$367.592$273.985$183.116
Operating Income$-623.046$-814.826$-572.023$-332.165$-267.83$-169.037
Total Non-Operating Income/Expense$5.037$24.673$16.585$-3.268$3.711$2.314
Pre-Tax Income$-618.009$-790.153$-555.438$-335.433$-264.119$-166.723
Income Taxes$0.686$-0.545$0.187$0.21$-0.612$0.06
Income After Taxes$-618.695$-789.608$-555.625$-335.643$-263.507$-166.783
Other Income------
Income From Continuous Operations$-618.695$-789.608$-555.625$-335.643$-263.507$-166.783
Income From Discontinued Operations------
Net Income$-618.695$-789.608$-555.625$-335.643$-263.507$-166.783
EBITDA$-603.69$-797.392$-554.865$-318.627$-258.182$-161.618
EBIT$-623.046$-814.826$-572.023$-332.165$-267.83$-169.037
Basic Shares Outstanding625552443735
Shares Outstanding625552443735
Basic EPS$-9.95$-14.31$-10.68$-7.71$-7.07$-4.81
EPS - Earnings Per Share$-9.95$-14.31$-10.68$-7.71$-7.07$-4.81
# 2020 2019 2018 2017 2016 2015
Current Ratio5.97065.15339.690613.83489.716712.9797
Long-term Debt / Capital--0.0752---
Debt/Equity Ratio--0.0813---
Gross Margin97.847993.333998.378595.6897100100
Operating Margin-248.4888-1823.938-1048.064-937.6041-4351.421-1200.632
EBIT Margin-248.4888-1823.938-1048.064-937.6041-4351.421-1200.632
EBITDA Margin-240.7691-1784.913-1016.627-899.3904-4194.67-1147.937
Pre-Tax Profit Margin-246.4799-1768.709-1017.677-946.8287-4291.129-1184.196
Net Profit Margin-246.7536-1767.489-1018.02-947.4216-4281.186-1184.622
Asset Turnover0.14080.02590.02430.01860.00550.014
Inventory Turnover Ratio------
Receiveable Turnover---11.3840.7206-
Days Sales In Receivables---32.0626506.5524-
ROE - Return On Equity-45.6583-61.4484-29.475-20.6749-30.3077-19.6101
Return On Tangible Equity-46.4525-62.79-29.892-21.0649-31.5344-20.5167
ROA - Return On Assets-34.7337-45.7102-24.7732-17.6602-23.5669-16.6394
ROI - Return On Investment-45.6583-61.4484-27.2581-20.6749-30.3077-19.6101
Book Value Per Share20.397623.208234.438132.85921.366923.0524
Operating Cash Flow Per Share2.6614-2.2804-1.5013-1.3577-2.2475-0.5904
Free Cash Flow Per Share3.4822-2.4962-1.1428-2.0357-2.7957-0.4659

Porovnání s konkurencí: Akcie BLUE

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
BLUE N/A 0.04 -79.03 % -9.86 % -66.53 % 1.03 -246.75 %
Akcie BMRN 16.78 2.77 3.76 % -105.99 % 20.22 % 3.42 46.18 %
Akcie GLYC 0.00 N/A N/A % 10.34 % -46.01 % 0.82 -502.09 %
Akcie MRK 35.60 1.38 2.87 % 13.14 % 19.42 % 7.90 14.72 %
Akcie SGMO N/A 0.47 23.58 % 3,300.00 % -27.95 % 2.56 -102.37 %
Akcie SGMO N/A 0.47 23.58 % 3,300.00 % -27.95 % 2.56 -102.37 %
Akcie XLRN N/A N/A 15.39 % 50.00 % -26.91 % 12.51 -179.45 %

Nedávné obchody insiderů: Akcie BLUE

Jméno Obchod Cena Objem
Nick Leschly
President and CEO
Prodej
2 Mar 2021
$29.58 $13,134
Jason Cole
Chief Operating
Prodej
2 Feb 2021
$45.93 $1,745
Nick Leschly
President and CEO
Prodej
2 Feb 2021
$45.93 $27,282
David Davidson
Chief Medical Officer
Prodej
2 Feb 2021
$45.93 $2,894
Andrew Obenshain
President of SGD
Prodej
2 Feb 2021
$45.93 $1,562
William D Iii Baird
Chief Financial Officer
Prodej
12 Feb 2021
$45.52 $55,352
David Davidson
Chief Medical Officer
Prodej
16 Feb 2021
$28.16 $19,656
Philip D Gregory
Chief Scientific Officer
Prodej
16 Feb 2021
$28.16 $18,698
Jason Cole
Chief Operating
Prodej
16 Feb 2021
$28.16 $18,726
Andrew Obenshain
President of SGD
Prodej
16 Feb 2021
$28.16 $21,092
Katy Burnett
Principal Accounting Officer
Prodej
16 Feb 2021
$28.16 $14,587
William D Iii Baird
Chief Financial Officer
Prodej
16 Feb 2021
$28.16 $19,515

Diskuze k akciím BLUE